Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_assertion type Assertion NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_head.
- NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_assertion description "[Altogether, the data showed that (a) circulating testosterone may act with estrogenic effects downstream in the catabolic process present in the prostate, and (b) that the estrogenic effect of testosterone derivatives (ERbeta-dependent) results in the inhibition of cell migration, although it is apparently different from that linked to estradiol on the same receptor and may be protective against prostate cancer invasion and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_provenance.
- NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_assertion evidence source_evidence_literature NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_provenance.
- NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_assertion SIO_000772 15958594 NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_provenance.
- NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_assertion wasDerivedFrom befree-20150227 NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_provenance.
- NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_assertion wasGeneratedBy ECO_0000203 NP385731.RAGiO4hoHsyU3IciQM63mhfP0InnF9O9Dc6Nr3fA1yKYQ130_provenance.